Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

88
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
88
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
79
  1. Home
  3. Research Domains
  5. Physical Sciences
  7. Condensed Matter Physics
  9. Condensed Matter Characterisation Technique Development
  11. Endoscopic Ultrasound-guided Pancreatic Cystic Fluid Biochemical And Genetic Analysis For The Differentiation Between Mucinous And Non-mucinous Pancreatic Cystic Lesions.

Endoscopic Ultrasound-Guided Pancreatic Cystic Fluid Biochemical and Genetic Analysis for the Differentiation Between Mucinous and Non-Mucinous Pancreatic Cystic Lesions.

Angelo Bruni1,2, Luigi Tuccillo1,2, Giuseppe Dell'Anna3,4

  • 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola, 40138 Bologna, Italy.

Journal of Clinical Medicine
|June 13, 2025

Related Experiment Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.2K
Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy
09:32

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Published on: May 5, 2023

817
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

370

View abstract on PubMed

Summary
This summary is machine-generated.

Accurate diagnosis of pancreatic cystic lesions (PCLs) is crucial. Intracystic glucose measurement is a sensitive and specific tool for differentiating mucinous PCLs from non-mucinous PCLs, outperforming traditional markers.

Area of Science:

  • Gastroenterology
  • Oncology
  • Medical Diagnostics

Background:

  • Pancreatic cystic lesions (PCLs) are increasingly detected, with a prevalence of 2-45%.
  • Differentiating mucinous PCLs (M-PCLs) from non-mucinous PCLs (NM-PCLs) is critical due to the malignant potential of M-PCLs.
  • Carcinoembryonic antigen (CEA) has limitations in sensitivity and specificity for PCL subtyping.

Purpose of the Study:

  • To evaluate the efficacy of intracystic glucose measurement in differentiating PCL subtypes.
  • To compare the diagnostic performance of glucose measurement with CEA and molecular biomarkers.
  • To explore the integration of glucose assessment and molecular assays for improved risk stratification.

Main Methods:

  • Endoscopic ultrasound-guided aspiration of PCL fluid.
Keywords:
intracystic glucosemucinous differentiationpancreatic cystic

Related Experiment Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.2K
Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy
09:32

Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy

Published on: May 5, 2023

817
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

370
  • Measurement of intracystic glucose levels using standard glucometers.
  • Analysis of DNA biomarkers (KRAS, GNAS mutations) in PCL fluid.

    • Main Results:

    • Intracystic glucose levels accurately differentiate PCL subtypes, with a reported cut-off of 30-50 mg/dL.
    • Glucose measurement demonstrates high sensitivity (88-95%) and specificity (76-91%), often exceeding CEA performance.
    • DNA biomarkers enhance specificity but have moderate sensitivity and require specialized platforms.

    Conclusions:

    • Intracystic glucose measurement is a valuable, accessible tool for PCL subtyping.
    • Combining glucose assessment with molecular markers refines risk stratification for PCL management.
    • Standardized protocols and cost-effective genetic testing are needed for routine clinical integration.